Purpose To describe a novel method of global cell viability assessment for Descemet membrane endothelial keratoplasty (DMEK) and the comparison of two contemporary methods of donor tissue preparation.
Methods DMEK transplants were prepared using two different methods: liquid bubble separation and manual peeling (n=8 each group). Samples were incubated with Hoechst, calcein-AM and ethidium homodimer prior to mounting on a curved imaging chamber. Z-stacked fluorescence microscopy images were combined to produce an in-focus global image capable of resolving all cell nuclei. Image processing software was used to define a calcein-positive live cell area, count all cell nuclei within this area and subtract ethidium-positive dead cells to derive the total viable endothelial cell count. Corrected global cell density was calculated by dividing the number of viable cells by the graft area, which had been corrected for imaging a curved surface.
Results Corrected global cell density was lower than the central endothelial cell density in both groups: 85.5% of the pre-preparation central endothelial cell density in the peel group and 75.8% in the bubble group. Corrected global cell density was significantly lower in the liquid bubble separation group than in the peel group (p=0.04).
Conclusions Eye bank estimations of central endothelial cell density overestimate true cell density after graft preparation in DMEK. A peel method is less damaging and more consistent than a liquid bubble method. Cell loss correlated strongly with the degree of stromal hydration prior to bubble separation in the liquid bubble group.
- Eye (Tissue) Banking
- Treatment Surgery
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
Selective endothelial keratoplasty (EK) techniques have replaced penetrating keratoplasty (PK) as the leading treatment modality for corneal endothelial failure.1 Descemet membrane EK (DMEK), the latest iteration of EK, is reported to have better visual outcomes, faster visual recovery2 and lower rates of rejection3 than other forms of EK.
While data from single surgeon, high volume centres suggest that graft survival and endothelial cell (EC) loss in DMEK can approximate figures quoted for PK,4 data from large registries suggest that EK survival is significantly shorter than that for PK, with the worst results being reported for DMEK.1
Graft registry data have established a link between donor EC density (ECD) and graft survival.5 Extrapolation of PK survival data has been used to derive the minimum ECD required for an acceptable median graft survival time,6 with most eye banks adopting a minimum central ECD of approximately 2200 cells/mm2 as a cut-off for donor tissue use in transplantation.
Viable ECs do not cover the entire endothelial surface of any corneal transplant. Hypotonia-induced stromal folds are often devoid of cells, with the adjacent areas containing high numbers of dead and dying cells.7 ,8 Additionally, iatrogenic endothelial damage occurs at every stage of the journey from donor retrieval to implantation, including storage,9 dissection,10 trephination,11 insertion12 or suturing.13 Consequently, patterns of cell damage vary between PK and EK. In EK, the insertion technique and the size of the wound used are also known to affect the patterns and degree of endothelial damage induced.14 This ‘transplantation trauma’ is thought to account for the significant drop in early postoperative ECD compared with donor ECD measured in the eye bank. Preoperative9 and early postoperative ECD has been shown to have a significant positive correlation with graft survival.15 Ongoing EC loss also occurs at a higher rate than in non-transplanted corneas.6
Given the relatively high rates of primary and early graft failure in DMEK,1 it is particularly important to minimise any tissue damage during donor tissue preparation. Preparation techniques described divide broadly into those based on peeling descemet membrane (DM) with forceps,16 ,17 and techniques aiming to separate DM from the corneal stroma with a fluid injection18–20 (either air or liquid). Most evaluations of these techniques focus on macroscopic donor tissue integrity with little or no comment on endothelial viability. Where endothelial viability is evaluated, different techniques have been used, making direct comparisons difficult.
Evaluating EC viability in DMEK is more challenging than for other forms of EK, as DMEK donor tissue scrolls upon itself when immersed, and artefactual tissue trauma may occur when unrolling specimens for imaging.
The most commonly described method is based on dual staining with trypan blue and alizarin red.12 ,21 There are several limitations to this approach. It is probable that trypan blue staining systematically underestimates EC mortality by failing to recognise apoptotic cells.8 Also, the trypan blue stained nuclei of individual dead cells may not be resolved by standard macroscopic photography.22 Smaller, non-contiguous areas of dead cells may therefore be included incorrectly in macroscopically viable areas. Extrapolation from small central high power fields to global estimates of viable ECD may also be problematic. In addition to the risk of sampling bias, ECD increases from the corneal apex to the periphery,23 and cell death is not uniform across the cornea.7 Methods of whole corneal assessment either ignore the biasing effect of corneal curvature or involve creating radial incisions to flatten the tissue.8 ,24
Here, we describe an atraumatic method for imaging the entire donor specimen in DMEK at the cellular level, using nuclear staining to facilitate accurate automated cell counting and a calcein-AM/ethidium homodimer, live/dead assay, which may overcome some of the limitations listed above for trypan blue and alizarin red.24 Using this novel method for quantifying donor endothelial viability, we compare contemporary peeling and fluid bubble separation techniques for DMEK donor preparation.
The ethical approval for study protocol was received from the institutional review board. All procedures conformed to the tenets of the Declaration of Helsinki.
Human corneoscleral buttons with consent for research use were obtained from Miracles of Sight Eye bank, North Carolina, USA. Tissue processing and experimentation were performed by a single surgeon (MB) with experience of >100 DMEK tissue preparations. All tissue had a central EC count of >2200 cells/mm2 and had been stored in Optisol GS (Bausch & Lomb, Rochester, New York, USA) for no longer than 14 days prior to experimentation. Initial cell density measurement was performed by specular microscopy in the eye bank supplying the tissue. Prior to experimentation, specimens were assessed using 0.4% trypan blue (Sigma, St. Louis, Missouri, USA) and excluded if large areas of cell loss were visible.
Samples were assigned to one of two methods of DMEK preparation (n=8 in each group). When paired tissue was available, one cornea from each pair was assigned to each intervention. Unpaired tissue was assigned alternately.
Two alternate methods of DMEK preparation were compared: manual peeling,16 using a technique widely applied to prepare DMEK tissue immediately prior to surgery, and liquid bubble separation,20 following the method described by Europe's largest Eye Bank (the Venice Eye Bank).
Corneoscleral rims were placed on a punch block from the Coronet trephine (Network Medical Products, Yorkshire, UK). Using a blunt Sinsky hook, the peripheral DM was scored circumferentially (360°) 0.5 mm anterior to Schwalbe’s line. An area of the scored DM edge free of radial tags was grasped with a single pair of fine non-toothed forceps and the DM peeled away from the underlying stroma approximately half way across the cornea under balanced salt solution (BSS). The DM was then replaced flat against the stroma by drying liquid away from beneath the peeled DM using a cellulose sponge, and a partial thickness 8.00 mm trephination performed. The redundant peripheral ring of endothelium between the trephination and score site was removed to confirm complete 360° trephination. The free edge of the 8.00 mm diameter DMEK donor specimen was then grasped at a single point, and donor peeling was completed under BSS.
Liquid bubble separation
Corneoscleral rims were placed on a punch block, as described above. A 25-gauge needle mounted on a 2.5 mL syringe filled with Optisol GS was inserted superficially through the tissue just peripheral to the pigmented trabecular meshwork and advanced until the entire bevel was located 0.5 mm anterior to Schwalbe's line. Optisol GS was injected in 0.1 mL aliquots until a peripheral separation ‘bubble’ between the stroma and DM could be seen. If 0.3 mL of liquid had been injected into the stroma without a successful bubble formation, the same process was attempted at a site 180° opposite. The total amount of liquid injected into the stroma prior to initial bubble formation was recorded for each specimen. Once a bubble had been initiated, liquid was injected until the bubble had spread to the trabecular meshwork at the opposite site of the corneal button. The peripheral DM was subsequently pierced with a 27-gauge needle and liquid was drawn from the bubble space using a cellulose sponge placed on the scleral rim. Once all visible liquid had been removed, an 8.00 mm trephination was performed to complete the preparation of the DMEK donor specimen.
Prepared DMEK donor scrolls were left on the stromal surface of the corneoscleral button and placed into a 12-well plate. Each sample was covered with 250 μL of BSS containing Hoechst 33342 (10 μM), ethidium homodimer II(4 μM) and calcein-AM (2 μM) (Invitrogen, Carlsbad, California, USA) and incubated at 37°C for 30 min.
Hoechst 33342 and ethidium homodimer II are nuclear binding dyes that do not fluoresce until they are bound to nuclear DNA. Hoechst 33342 readily penetrates intact cell membranes and binds to the nuclear DNA of all ECs (both living and dead). Ethidium homodimer II is only able to penetrate compromised cell membranes of dead/dying (necrosis and late apoptosis). Calcein-AM readily travels through the cell membrane and is metabolised to brightly fluorescent calcein by cytosolic esterases. Dead cells are either unable to metabolise calcein-AM to fluorescent calcein or unable to retain fluorescent calcein owing to their compromised cell membranes. Hoechst, ethidium and calcein are visible in the DAPI, TRITC and FITC channels of the fluorescence microscope, respectively.
After incubation and staining, the samples were gently rinsed with BSS and mounted for imaging in a customised chamber designed to match the curvature of the DMEK donor (figure 1A). Drops of BSS and the capillary action of partial drying with absorbent cellulose sponges were used in a ‘no touch’ technique to orientate the DMEK donor samples flat on the curved surface, endothelial side up. The endothelial surface was then covered with viscoelastic (Provisc, Alcon, Fort Worth, Texas, USA) before chamber and imaging with the ×4 objective (Nikon CFI Plan Fluor 4X) of a Nikon Eclipse Ti-E inverted fluorescence microscope (Nikon, Tokyo, Japan; figure 1B). Dimensions from the curved imaging chamber were used to calculate the true graft area (figure 1C)
To image the entire graft surface, multiple image tiles were combined and stitched together using the integrated software accompanying the microscope (NIS Elements AR V.4 (Nikon, Tokyo, Japan)). Each image tile consisted of a z-stack of 20–40 individual images. In-focus information from each image was combined using the enhanced depth of focus software module to produce a single tile. With this technique, it was possible to visualise every individual cell across the entire graft surface.
Image processing and outcome measures
Images were exported to the open source NIH ImageJ software (National Institutes of Health, Bethesda, Maryland, USA) for processing and analysis (figure 2). For each DMEK specimen, the graft area and the area of viable cells were manually defined (figure 3A, B), and the differences between the two used to calculate the damage caused by tissue trephination.
The FITC/calcein channel image underwent a process of thresholding, segmentation and processing to remove image artefacts and background noise (figure 3C, red area). This area was used to create a mask using the ‘create selection’ function in ImageJ. From this binary image (figure 3C, green outline), we were able to calculate the percentage area of the graft covered by viable cells (=viable cell area/total graft area) and the percentage cell coverage excluding the trephination damage area (=viable cell area/total graft area—trephination damage area).
All ultraviolet/Hoechst and TRITC/ethidium-staining nuclei within the viable cell area were identified and counted using the ITCN nucleus counting plugin for ImageJ (figure 3D, E), after this method had been validated against manual counts.
The viable graft area included cells staining with both ethidium and calcein. These may represent dying cells within the endothelial monolayer or dead cells that have become detached and are sitting on top of the monolayer.
Total viable cell number was calculated by subtracting the number of ethidium-positive cells from the number of Hoechst-positive cells. Corrected global ECD was then calculated by dividing viable cell number by the corrected graft area. The corrected global ECD (total viable ECs/graft area) was normalised for each sample by dividing it by the measured central cell density taken from a central area of confluent cells.
Statistical comparisons were performed using GraphPad Prism (GraphPad Software, La Jolla, California, USA) using two-tailed t tests with a threshold for statistical significance set at p<0.05. A qualitative comparison of patterns of cell loss was also performed.
Comparison of peeling versus liquid separation
There were no statistically significant differences in donor age, death to storage time or eye bank measured central ECD between the two groups (pre-preparation graft characteristics are presented in table 1).
The percentage area covered by viable cells was significantly higher in the peel group.
In spite of using the same diameter trephine in all samples, average graft area was significantly higher in the DM bubble group. There was no statistically significant difference in the area of damage caused by trephination between the two groups (table 2).
After individual cell viability assessment, the total number of living cells was divided by the true graft area to give a global cell density. This was divided by the central ECD to correct for starting variations in cell density and expressed as a percentage of the central ECD. Corrected global cell density was 85.5±4.7% of central ECD in the peel group and 75.8±12.4% of central ECD in the bubble group, p=0.04. We observed a larger variation in tissue viability for the liquid bubble method of donor tissue preparation. To investigate this further, a post hoc comparison between the amount of liquid injected into the stroma prior to DM bubble formation (stromal hydration) and graft viability was made using laboratory notes from the experimentation. There was a strong correlation between the amount of tissue hydration and the area of viable cells (R=−0.96, p<0.001; figure 4).
Patterns of cell loss
Linear areas of cell loss corresponding to folds in the tissue could be seen in both groups and closely corresponded to the observed pattern witnessed using trypan blue staining prior to tissue preparation (figure 5A, B). In the DM bubble group, an area of increased cell loss was often observed at the point of initial bubble formation (figure 5C, D).
We have described a novel method of DMEK graft viability assessment that eliminates the need for radial incisions to flatten graft tissue, limits iatrogenic mounting trauma and fully accounts for variations in cell density and cell death across the whole specimen. To our knowledge, this represents the first method of endothelial viability assessment conducted on an individual cell level across the entire surface of a corneal transplant in living tissue.
Using this technique, we found that a peeling method, commonly used by surgeons preparing grafts in theatre and employed by eye banks shipping pre-stripped tissue in the USA (Miracles of Sight Eye Bank) and Europe (Amnitrans Eye Bank, Rottterdam, the Netherlands), is reliable and produces minimal EC damage. The percentage area of non-viable tissue in the peeled samples was 12%, however, 5% of the non-viable graft area is attributable to trephination damage alone. Qualitative comparison with trypan blue staining prior to tissue dissection suggests that the majority of non-viable areas are present on the transplant tissue prior to preparation, with non-viable cells concentrated within tissue folds.
The corneal endothelium heals primarily by a process of wound repair in which cells enlarge and spread with minimal cell division occurring in vivo.25 Cell loss during tissue storage and preparation is therefore likely to map directly to postoperative ECD9 and the prognosis for DMEK graft survival. A detailed understanding of where cell loss can be avoided should ultimately improve graft outcomes and survival. We were able to detect a significant difference between two DMEK preparation techniques, where other authors using more simplistic methods could not.26 Although our method is more time-consuming, we believe it significantly improves upon those previously described assessments in whole grafts.27 ,28
Our findings compare favourably with those reported by other authors assessing endothelial viability in DMEK preparation. Jardine et al27 used calcein-AM alone to assess areas of cell loss after preparation of DMEK transplants using a peel technique. They found that 22.5% of the graft area was non-viable, and inspection of the figures in their paper suggests this may not include the damage caused by trephination. As acknowledged by the authors themselves, it is likely that the higher degree of cell damage reported previously is, in part, due to the method of tissue mounting used. Using our technique, we were able to minimise trauma associated with specimen manipulation. Our relatively good results may therefore reflect the degree of cell damage associated with DMEK donor preparation more accurately.
The amount of stromal hydration accounts for approximately 85% (R2) of the variability in endothelial damage observed in the liquid separation group. Excessive stromal hydration increases tissue strain,22 and this is likely to transfer mechanical stress directly to the ECs. Tissue distortion and mechanical stress have been implicated in both acute EC trauma7 and cell death during tissue storage.20 In grafts in which a separation plane under the DM could be induced with minimal hydration, tissue viability was comparable with that of a peel technique. We did not observe a learning effect whereby excessive tissue hydration was limited to the earlier samples in the liquid bubble group. Instead, the amount of liquid needed may relate to the adhesion between the stroma and DM and be an intrinsic property of the tissue itself. It has been suggested that grafts stored in organ culture without dextran may be easier to separate using a liquid separation method20 and therefore induce less endothelial damage. Direct transfer of methods of DMEK preparation tested in organ culture to corneas in cold storage may not be appropriate and specific validation should be carried out for each storage method.
In addition to counting all viable cells, our method also takes into account the true surface area of the curved posterior corneal surface when calculating cell density. Since the area of a spherical cap is greater than that of a circle of the same diameter, previous studies may have systematically overestimated cell density at the point of transplantation.29 Global cell density was on average 14.6% lower than central cell density in the peel group and 24.2% lower in the bubble group, suggesting that an early postoperative ECD reduction of up to 25% could be expected from tissue preparation alone.
For the preparation of DMEK scrolls from cold stored corneal tissue, based on results here, we would recommend techniques based on peeling rather than fluid bubble separation. Higher cell damage for the liquid bubble technique observed here may not translate to techniques for deep anterior lamellar keratoplasty, since corneal ECs undergo changes in storage that make them less resistant to mechanical damage.30
A future simple method of reducing endothelial mortality may involve limiting the damage induced by trephination. Further experimentation to determine whether ongoing cell loss during storage of pre-prepared DMEK grafts differs between the peel and bubble separation methods is warranted.
Tissue for experimentation was supplied by Miracles of Sight Eye bank, Salem, North Carolina, USA. The customised viewing chamber used in our experimentation was produced by the scientific workshop, UCL Institute of Ophthalmology, London, UK.
Contributors MB: conception of the work. Acquisition, analysis interpretation of data and drafting of manuscript. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. MB, KM, BDA: design of the work. Interpretation of data and revision of manuscript. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding The work presented in this paper is supported by an MRC clinical training research fellowship to MB. Equipment and reagents used in this work have been paid for by grants from the Wellcome Trust and BBSRC (MB and KM). This study was supported by a multiuser equipment grant from The Wellcome Trust [099173/Z/12/Z]. This research has received a proportion of its funding from the Department of Health's NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology (BDA).
Disclaimer The views expressed in the publication are those of the authors and not necessarily those of the Department of Health.
Competing interests None declared.
Ethics approval Institute of Ophthalmology, UCL.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.